Akebia to Present Global Phase 3 Vadadustat Data at American Society of Nephrology Kidney Week 2020 Reimagined Transcript

Oct 23, 2020 / 08:10PM GMT
Operator

Good day, ladies and gentlemen, and welcome to Akebia Therapeutics Investor Briefing Webcast. As a reminder, this webcast is being recorded.

I would now like to introduce your host for today's event, Kristen Sheppard.

Kristen K. Sheppard - Akebia Therapeutics, Inc. - VP of IR

Thank you, and welcome to Akebia's Investor Briefing Webcast to discuss the global Phase III data for vadadustat for the treatment of anemia due to chronic kidney disease, presented at the American Society of Nephrology Clinical Meeting yesterday and also earlier today.

Please note that the slides for today's event are available on our Investor Relations website. For your convenience, a replay of today's webcast will also be available on our website shortly after we conclude today's event.

Joining me for today's event is John Butler, our Chief Executive Officer; Dr. Steven Burke, our Chief Medical Officer; and Dr. Glenn Chertow, Professor of Medicine, Chief of the Division of Nephrology at Stanford University and the Co-Chair of the Independent Executive

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot